Skip to content
Search AI Powered

Latest Stories

England’s top mental health nurse urges people to look out for dementia warning signs

England’s top mental health nurse urges people to look out for dementia warning signs

NHS staff diagnosed 463,797 people aged over 65 with dementia in November 2023, up more than 41,000 compared to the same period last year.

Dementia is an extremely deceptive disease that develops slowly and may go unnoticed in people, said NHS mental health director Claire Murdoch, while urging people to look out for the vital warning signs of this condition among family and friends over Christmas.


Common early symptoms of dementia may include emotional change, forgetfulness, difficulty concentrating, struggling to follow a conversation or find the right word, being confused about time and place, the health service has cautioned.

An increasing number of people have been diagnosed with dementia in England since the start of the pandemic, following a drive by the NHS England to increase diagnosis rates.

In November 2023, NHS staff diagnosed 463,797 people aged over 65 with dementia, up more than 41,000 compared to the same period last year, according to the figures revealed by the health service.

To identify more people with dementia, the NHS launched 14 pilots across the country which involve health professionals going into care homes to assess older adults who may have missed checks during the pandemic.

The target is to complete diagnosis of 66.7 per cent of people over 65 for dementia by next year, and three regions in London, North West, and North East and Yorkshire have already achieved it.

The NHS has also launched a £5m project to introduce new blood tests that can diagnose Alzheimer’s disease.

It will be easier to spot dementia warning signs when families and friends get together over the festive season, Murdoch said.

“There are lots of reasons why people might be forgetful or absent-minded at such a busy time of the year, but it could also be the sign that something can be wrong.

“Getting a diagnosis for dementia is the first step in supporting people with a wide range of NHS services able to help.

“Thanks to the efforts of NHS staff, tens of thousands more people are now getting a dementia diagnosis than this time last year which opens up doors to further support for patients and their families who experience this heart-breaking disease.

“If you have noticed that someone has symptoms, please encourage them to visit their GP for an assessment – the sooner someone is seen the quicker the NHS can help,” she added.

NHS data showed that around 944,000 individuals are currently living with dementia in the UK, and over 750,000 of these patients are from England.

“Dementia is the UK’s biggest killer,” said James White, Head of National Influencing at Alzheimer’s Society, adding that it can often be mistaken for simply old age but “it’s not a natural part of ageing and it doesn’t just affect older people.”

Despite so many people living with dementia in the UK, there’s a lack of awareness of its symptoms, noted Dr Susan Mitchell, Head of Policy – Prevention, Early Detection and Diagnosis at Alzheimer’s Research UK.

“For example, one in two people aren’t aware that memory loss as a sign of the condition, and there’s even lower awareness of other signs, such as problems in communicating, low mood and anxiety, and confusion,” she added.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less